Tactogen | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

29 results for “Tactogen”

Trials

View all 17 →

Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage

3 participants · First posted Feb 5, 2020

Low-Dose Decitabine in Treating Patients With Symptomatic Myelofibrosis

4 participants · First posted Mar 7, 2008

Dietary Supplementation of Lactogyn in Women With Bacterial Vaginosis

166 participants · First posted Jul 26, 2018

Drugs

Entactogen NCEs

LHPP saRNA(Ractigen)

Lactobacillus Plantarum ATG-K2(AtoGen Co. Ltd)

Organizations

Ractigen Therapeutics

China

News

FDA Rejection of MDMA Therapy for PTSD Triggers Industry Reprioritization

Antogen Secures Seed Financing to Advance Next-Generation Immune Surveillance Diagnostics

Ractigen's RAG-18 Receives FDA Orphan Drug Designation for Duchenne and Becker Muscular Dystrophy

Page 1 of 3